Explore the detailed record of transactions filed by Julie Hill. Director active across 1 company, notably Hikma Pharmaceuticals PLC. Aggregated, 11 filings have been published. Activity tracked since 6 March 2024. The latest transaction was filed on 5 May 2026 (Purchase). Regulator: RNS (LSE). All data is accessible without signup.
Companies and markets linked to Julie Hill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Julie Hill is a PDMR at Hikma Pharmaceuticals PLC (XLON). She has 11 filings in total, and within the sampled recent filings, the period runs from 2024-03-07 to 2026-05-06, with purchases of EUR 8783 and no sales.